Neonc Technologies Holdings Inc (NTHI) - News Archive

NeOnc Technologies to Highlight Advances in Brain Cancer Research on Nationwide TV Broadcast On September 25, 2025, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a clinical-stage biotechnology company specializing in...

In a landmark announcement, NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) has received authorization from the U.S. Food and Drug Administration (FDA) to advance to Phase II clinical trials for its pioneering oral che...

NeOnc Technologies Nears Completion of Phase I Enrollment for Promising Brain Cancer Therapy NeOnc Technologies, a biopharmaceutical company focusing on developing novel solutions for cancer treatment, has announced it...

In a strategic move for expansion and innovation, NeOnc Technologies prepares for a significant milestone that is likely to shape its future trajectory. The biotechnology company, renowned for its innovative approaches...

Navigating New Frontiers in BiotechnologyNeOnc Technologies Holdings, Inc. is poised at an exciting juncture in its corporate evolution, marked by significant leadership appointments, strategic financing, and a forthcom...

NeOnc Technologies Raises $18.5 Million to Overcome Blood-Brain Barrier in Clinical TrialsIn a recent development, NeOnc Technologies Holdings, Inc., a clinical-stage medical biotechnology company based in Westlake Vill...

Clinical-stage biopharmaceutical company, NeOnc Technologies, has recently been honored with the prestigious Breakthrough Medical Technology Achievement Award at the California Investment Forum. This recognition undersc...

NeOnc Technologies Nominated for Breakthrough Medical Technology Achievement Award at California Investment ForumNeOnc Technologies, a Southern California-based clinical-stage biopharmaceutical company specializing in n...